Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

Express Scripts reports higher Q4 net income, provides Q1 guidance

Express Scripts Holding Company, a pharmacy benefit management organization, has reported that net income attributable to the company for the fourth quarter ended December 31, 2014 was $581.8 million, or $0.79 per diluted share, compared to $501.9 million, or $0.63 per diluted share, for the same quarter ended December 31, 2013. For first quarter ending March 31, 2015, the company expects adjusted earnings per diluted share to be in the range of $1.07 to $1.11.

Published By MarketLine
27 Feb 2015
NewsWire
NewsWire

Sanofi receives FDA approval for treatment of diabetes

Sanofi has received the FDA approval for Toujeo, a once-daily long-acting basal insulin, used to improve glycemic control in adults living with type 1 and type 2 diabetes.

Published By MarketLine
27 Feb 2015
NewsWire
NewsWire

Illumina launches new library preparation system

Illumina, Inc., a provider of sequencing and array-based technologies, has launched a NeoPrep Library Prep System.

Published By MarketLine
27 Feb 2015
NewsWire
NewsWire

Sunovion initiates enrollment in Phase III COPD trial

Sunovion Pharmaceuticals Inc. has initiated the enrollment in Phase III clinical trial program for SUN-101 inhalation solution delivered through the investigational eFlow nebulizer system, or SUN- 101/eFlow, from PARI Pharma GmbH. SU-101/eFlow is being investigated for the twice-daily maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease, or COPD, including chronic bronchitis and emphysema.

Published By MarketLine
27 Feb 2015
NewsWire
NewsWire

Meridian Bioscience receives CE mark for S. pneumo detection test

Meridian Bioscience, Inc., a developer of clinical diagnostic test kits, has received the CE mark for TRU STREP PNEUMO, its new test for Streptococcus pneumonia, or S. pneumo.

Published By MarketLine
27 Feb 2015
NewsWire
NewsWire

Gilead announces encouraging results from Phase III HIV-HCV co-infection study

Gilead Sciences, Inc., a biopharmaceutical company, has announced results from a Phase III study, ION-4, evaluating the once-daily single tablet regimen Harvoni for the treatment of genotypes 1 or 4 chronic hepatitis C virus, or HCV, infection among patients co-infected with HIV.

Published By MarketLine
27 Feb 2015
NewsWire
NewsWire

Corgenix receives EUA from FDA for Ebola rapid diagnostic test

Corgenix Medical Corporation, a developer of diagnostic test kits, has received FDA emergency use authorization, or EUA, for its ReEBOV Antigen Rapid Test, to be used for the presumptive detection of Ebola Zaire virus in individuals with signs and symptoms of Ebola virus infection in conjunction and with epidemiological risk factors.

Published By MarketLine
27 Feb 2015
NewsWire
NewsWire

Teleflex Q4 net income up

Teleflex Incorporated, a medical technology company, has reported that net income attributable to the common shareholders for the fourth quarter ended December 31, 2014 was $50.64 million, or $1.07 per diluted share, compared to $34.83 million, or $0.77 per diluted share, for the same quarter ended December 31, 2013.

Published By MarketLine
27 Feb 2015
NewsWire
NewsWire

Revance Therapeutics appoints new director

Revance Therapeutics, Inc., a specialty biopharmaceutical company, has appointed Philip Vickers, executive vice president and global head of R&D at Shire plc, to its board of directors.

Published By MarketLine
27 Feb 2015
NewsWire
NewsWire

Masimo receives clearance for non-invasive PVI in Korea

Masimo Corporation, a medical technology company, has received clearance from the Republic of Korea's Ministry of Food and Drug Safety, or MFDS, and the Korean Health Technology Assessment, or HTA, group for the company's non-invasive Pleth Variability index, or PVI.

Published By MarketLine
27 Feb 2015

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.